Tag: gastric volvulus treatment industry

Uncover key drivers, emerging technologies, and competitive movements shaping the gastric volvulus treatment market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Gastric Volvulus Treatment Market’s size between 2026 and 2030?

The gastric volvulus treatment market size has experienced robust expansion in recent years. Projections indicate an increase in its valuation from $28.86 billion in 2025 to $30.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be ascribed to several factors, including the availability of various surgical treatment options, the expansion of hospital emergency care services, enhanced diagnosis through imaging tests, the evolution of gastropexy procedures, and advancements in surgical expertise.

The gastric volvulus treatment market size is anticipated to undergo substantial growth in the upcoming years. It is forecast to grow to $39.4 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.3%. The expansion during this forecast period stems from factors such as the increase in minimally invasive surgery, enhanced emergency response systems, the uptake of advanced imaging, the proliferation of specialty surgical centers, and heightened clinical awareness. Key trends predicted for the forecast period encompass a rising inclination towards surgical intervention, an increased embrace of minimally invasive procedures, improved emergency diagnosis and management, the expansion of specialized surgical care, and a concentrated effort on rapid treatment to decrease mortality.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Drivers Are Shaping Strategic Decisions In The Gastric Volvulus Treatment Market?

The expanding elderly demographic is projected to boost the gastric volvulus treatment market in the future. This demographic consists of individuals aged 65 years and above, who frequently experience various health issues due to declining immunity and advancing age. Given that gastric volvulus primarily affects adults over 50 years old, an increase in this older population is consequently expected to stimulate market growth. For example, data released in January 2024 by the Population Reference Bureau (PRB), a US-based nonprofit organization, anticipates a rise in the number of Americans aged 65 and older from 58 million in 2022 to 82 million by 2050, representing a 47% increase, and their proportion of the overall population is predicted to grow from 17% to 23%. Thus, the rising geriatric population acts as a significant driver for the gastric volvulus treatment market.

What Segment Categories Are Covered In The Gastric Volvulus Treatment Market?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

What Trends Are Projected To Support The Growth Of The Gastric Volvulus Treatment Market?

Major companies in the gastric volvulus treatment market are focusing on developing innovative solutions, such as next-generation oral immunomodulatory therapies, to address the growing demand for advanced treatment options that enhance long-term disease control and patient quality of life. These orally administered treatments target inflammatory and immune-driven mechanisms, presenting a more convenient and targeted alternative when compared with traditional systemic treatments that may carry higher side-effect risks and require more intensive management. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for people with moderate to severe active ulcerative colitis (UC). VELSIPITY’s official suggested dosage is 2 mg. VELSIPITY enables adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that has a positive benefit-risk profile. The FDA’s approval of VELSIPITY today signifies an important turning point for UC patients who need novel therapies for this long-term illness and are ready to begin advanced treatment.

Which Major Industry Participants Are Leading The Gastric Volvulus Treatment Market Growth?

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Region Is Projected To Lead The Gastric Volvulus Treatment Market During The Forecast Period?

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastric Volvulus Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2026, By The Business Research Company

Gastric Ulcers Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Gastroparesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Gas Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/gas-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Gastric Volvulus Treatment Market Today And What Is Its Future Size?

In the past few years, the gastric volvulus treatment market has been expanding steadily. The market is expected to rise from $27.36 billion in 2024 to $28.86 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. Factors such as breakthroughs in surgical methods, enhanced diagnostic technology, increased awareness and guidance, the growth of minimally invasive procedures, and medical research and studies have significantly contributed to the historical growth of this market.

Rapid escalation is anticipated in the gastric volvulus treatment market in the near future. The projection suggests that the market will develop to be a $37.18 billion industry by 2029, with an annual compound growth rate of 6.5%. A wide range of factors, such as regulatory revisions and endorsements, innovation in surgical methods, an expanding elderly population, tailor-made treatment strategies, and the use of high-tech imaging techniques, could be behind this growth during the forecast period. Noteworthy trends for this period encompass less invasive surgical procedures, early diagnosis and treatment, research advancements in treatment methods, collaborative practices in the medical field, and individualized treatment plans.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Key Factors Are Fueling Growth In The Gastric Volvulus Treatment Market?

The anticipated increase in the population of older adults, 65 years and above, is set to spur the development of the gastric volvulus treatment market. It’s acknowledged that this geriatric populace is prone to various diseases due to ageing and decreased immunity, including gastric volvulus, which particularly affects those over 50 years. Therefore, the expected escalation of the geriatric demographic will likely drive the market. For illustration, statistics released by the US-based Population Reference Bureau (PRB), a nonprofit institution, in January 2024 projects a shift in the number of Americans aged 65 and over from 58 million in 2022 to 82 million in 2050, being a 47% increase. Concurrently, their segment of the total population is indicated to rise from 17% to 23%. Consequently, increasing numbers of older adults could boost the gastric volvulus treatment market.

How Is The Gastric Volvulus Treatment Market Segmented Across Key Categories?

The gastric volvulus treatmentmarket covered in this report is segmented –

1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus

2) By Treatment Type: Medication; Surgery

3) By Route Of Administration: Oral; Parenteral

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy

5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches

What Future-Focused Trends Are Anticipated In The Gastric Volvulus Treatment Market?

The rise of product innovations in the gastric volvulus treatment market is a noticeable trend being endorsed by key players in the market. Major firms in the industry are stepping up their game by creating groundbreaking products to consolidate their market position. A case in point is when Pfizer Inc., a pharmaceutical enterprise based in the US, publicized in October 2023 that VELSIPITY (etrasimod) had received the stamp of approval from the U.S. Food and Drug Administration (FDA). It’s a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for individuals with moderate to severe active ulcerative colitis (UC). The recommended dosage for VELSIPITY is 2 mg. This revolutionary medication offers adults with active UC the chance for steroid-free resolution through an oral pill taken once daily that presents a favorable benefit-risk ratio. The endorsement of VELSIPITY by the FDA represents a significant milestone for UC patients seeking new treatments for their chronic condition, paving the way for advanced therapy.

Who Are The Leading Companies Driving The Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Region Dominates The Gastric Volvulus Treatment Market Today?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2025, By The Business Research Company

Wearable Blood Pressure Monitors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Conjugated Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/conjugated-monoclonal-antibodie-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Gastric Volvulus Treatment Market Worth In 2025, And What Is Its Anticipated Value By 2029?

Significant expansion has been observed in the gastric volvulus treatment market size recently. Forecasts suggest an increase from $27.36 billion in 2024 to $28.86 billion in 2025, driven by a 5.5% compound annual growth rate (CAGR). Over previous periods, this growth stemmed from progress in surgical methods, better diagnostic technologies, heightened awareness and education, an increase in minimally invasive interventions, and dedicated research and clinical trials.

The gastric volvulus treatment market is anticipated to show significant expansion over the next few years. It is projected to reach $37.18 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.5%. This forecasted growth can be attributed to regulatory adjustments and new approvals, innovations in surgical procedures, a rising geriatric population, the development of customized treatment plans, and the adoption of advanced imaging techniques. Notable trends during this period include the prevalence of minimally invasive surgical techniques, greater awareness leading to early intervention, intensified research into various treatment modalities, collaborative medical practices, and patient-specific treatment approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Drivers Are Supporting Growth Of The Gastric Volvulus Treatment Market?

The increasing demographic of older adults is projected to drive the expansion of the gastric volvulus treatment market in the future. This demographic encompasses individuals aged 65 and above. Due to diminished immunity and advancing age, the older adult population is susceptible to numerous health conditions. Specifically, gastric volvulus manifests in individuals aged over 50. Consequently, the expansion of the elderly demographic is anticipated to stimulate the market. For example, data from January 2024, released by the US-based nonprofit Population Reference Bureau (PRB), forecasts that the count of Americans aged 65 and above will rise significantly from 58 million in 2022 to 82 million by 2050, representing a 47% increase, with their share of the total population expanding from 17% to 23%. These demographic trends confirm that an increasing elderly populace is a primary driver for the gastric volvulus treatment market.

What Are The Key Segments In The Gastric Volvulus Treatment Market?

The gastric volvulus treatmentmarket covered in this report is segmented –

1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus

2) By Treatment Type: Medication; Surgery

3) By Route Of Administration: Oral; Parenteral

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy

5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches

What Trends Are Redefining The Gastric Volvulus Treatment Market Dynamics?

Product innovation represents a key trend experiencing growing popularity within the gastric volvulus treatment market. Leading companies operating in this market are introducing novel products to sustain their standing in the gastric volvulus treatment market. For example, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) functions as a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for individuals suffering from moderate to severe active ulcerative colitis (UC). VELSIPITY’s officially recommended dosage is 2 mg. VELSIPITY enables adults with moderately to severely active UC to attain steroid-free resolution through an oral, once-daily pill that exhibits a positive benefit-risk profile. The FDA’s approval of VELSIPITY today signifies an important turning point for UC patients who require innovative therapies for this chronic illness and are prepared to commence advanced treatment.

Who Are The Primary Competitors In The Global Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

What Regional Growth Trends Are Shaping The Gastric Volvulus Treatment Market Outlook?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Gastric Volvulus Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2025, By The Business Research Company

Wearable Blood Pressure Monitors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Conjugated Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/conjugated-monoclonal-antibodie-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Gastric Volvulus Treatment Market Size From 2025 to 2034?

In recent times, the market size for gastric volvulus treatment has seen a significant increase. It’s anticipated to expand from $27.36 billion in 2024 and reach $28.86 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to the growth during the historic period include advancements in surgical methodologies, enhancement of diagnostic technologies, increased awareness and education, a surge in minimally invasive procedures, and ongoing research and clinical studies.

A solid expansion is anticipated in the gastric volvulus treatment market, which is predicted to reach a size of $37.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. This growth trajectory over the specified forecast period can be credited to regulatory updates and authorizations, surgical procedure innovations, an increasing elderly population, personalized treatment strategies, and the embracing of high-tech imaging techniques. Key trends predicted for this period include the prevalence of minimally invasive surgery, increased awareness leading to early interventions, research into different treatment modalities, cooperation in medical practice, and the tailoring of treatment methods.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What are the Fundamental Drivers and Innovations Shaping the Gastric Volvulus Treatment Market?

The growth of the gastric volvulus treatment market is projected to be driven by an increasing geriatric population. This term is used to describe individuals aged 65 years and over, who tend to suffer from numerous diseases due to their age and declining immunity. Gastric volvulus, in particular, typically affects older adults over the age of 50. Therefore, the expanding geriatric demographic is likely to fuel this market. For example, the Population Reference Bureau (PRB), a nonprofit organization based in the US, released data in January 2024 suggesting that the American population aged 65 and above is estimated to rise from 58 million in 2022 to 82 million in 2050, marking a 47% increase. Furthermore, their proportion within the total population is predicted to grow from 17% to 23%. Hence, the swelling numbers of older adults are contributing to market growth for gastric volvulus treatments.

How Is the Gastric Volvulus Treatment Market Segmented?

The gastric volvulus treatmentmarket covered in this report is segmented –

1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus

2) By Treatment Type: Medication; Surgery

3) By Route Of Administration: Oral; Parenteral

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy

5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Which Regions Are Driving the Next Phase of the Gastric Volvulus Treatment Market Growth?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Gastric Volvulus Treatment Market?

The advent of product innovations is a notable trend escalating in prominence in the gastric volvulus treatment market. Leading corporations in this sector are launching revolutionary merchandise to maintain their presence in this market. For instance, Pfizer Inc., a pharmaceutical firm based in the US, announced in October 2023 that the US Food and Drug Administration (FDA) had given approval for VELSIPITY (etrasimod). This is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for people suffering from moderate to severe active ulcerative colitis (UC). The recommended dosage for VELSIPITY is set at 2 mg. It offers adults with moderately to severely active UC, the possibility of achieving steroid-free resolution with a once-daily, orally-administered pill that boasts a favourable benefit-risk ratio. The FDA’s consent rendered to VELSIPITY marks a critical milestone for UC patients in need of innovative treatments for their long-term ailment and are prepared to commence advanced therapy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

How Is the Gastric Volvulus Treatment Market Defined and What Are Its Core Parameters?

Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Gastric Volvulus Treatment Market Grown from 2024 to 2025?

In recent times, the market size for gastric volvulus treatment has seen robust growth. The market is anticipated to surge from $27.36 billion in 2024 to an increased value of $28.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The substantial growth noted in the historic period is due to factors such as developments in surgical procedures, enhancements in diagnostic technologies, heightened awareness and education, growth in minimally invasive procedures, and ongoing research and clinical studies.

What Growth Rate Is Anticipated for the Gastric Volvulus Treatment Market in the Coming Years?

In the coming years, the market for gastric volvulus treatment is expected to experience significant growth, reaching a value of $37.48 billion in 2029, with an annual compound growth rate of 6.7%. Factors contributing to this growth during the forecast period include regulatory shifts and approvals, advancements in surgery methods, increase in the elderly population, personalized treatment programs, and the usage of high-tech imaging techniques. The major trends projected for this period include a shift towards less invasive surgical techniques, a rise in early intervention and awareness, advances in treatment approaches, increased collaboration in medical practices, and tailored treatment options.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Who Are the Leading Companies in the Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

What Are the Key Drivers of the Gastric Volvulus Treatment Market?

The upsurge in the elderly population is projected to drive the growth of the gastric volvulus treatment market. Often called the geriatric population, this group includes adults aged 65 and above who are prone to multiple infections due to decreased immunity and elderly age. Gastric volvulus is specifically found in individuals above fifty years old, implying that an increase in the aging population would expedite the market growth. As an illustration, the Population Reference Bureau (PRB), a nonprofit organization based in the US, predicts in January 2024 that the number of Americans aged 65 and above will skyrocket from 58 million in 2022 to 82 million in 2050, envisioning a 47% upsurge. Furthermore, the percentage of this group in the overall population is forecasted to rise from 17% to 23%. Consequently, with the upswing in older populations, the gastric volvulus treatment market is being given a significant boost.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

What Are the Key Market Segments in the Gastric Volvulus Treatment Industry?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

What Are the Latest Trends in the Gastric Volvulus Treatment Market?

Innovations in product development are an emerging trend within the gastric volvulus treatment sector, with leading companies launching unique products to maintain market stronghold. For example, Pfizer Inc., an American pharmaceutical titan, revealed in October 2023 that the U.S. Food and Drug Administration (FDA) had sanctioned VELSIPITY (etrasimod), a once-daily oral pill for individuals dealing with moderate to severe active ulcerative colitis (UC). Officially, the recommended dosage for VELSIPITY is 2 mg. It enables adult patients with moderate to severe active UC to achieve a steroid-free resolution courtesy of a single daily pill with a favourable benefit-risk ratio. With the FDA’s endorsement, VELSIPITY stands as a critical game-changer for UC patients seeking new treatments for their chronic condition and are prepared for advanced treatment.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

What Are the Key Regional Markets in the Gastric Volvulus Treatment Industry?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

This Report Delivers Insight On:

1. How big is the gastric volvulus treatment market, and how is it changing globally?

2. Who are the major companies in the gastric volvulus treatment market, and how are they performing?

3. What are the key opportunities and risks in the gastric volvulus treatment market right now?

4. Which products or customer segments are growing the most in the gastric volvulus treatment market?

5. What factors are helping or slowing down the growth of the gastric volvulus treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gastric volvulus treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Gastric Volvulus Treatment Market Size from 2025 to 2034?

In recent times, the market size for gastric volvulus treatment has seen a vigorous expansion. The market is projected to expand from $27.36 billion in 2024 to $28.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. This growth during the historic period can be ascribed to the progression in surgical procedures, enhancements in diagnostic technologies, raised awareness and education, the surge in minimally invasive procedures, as well as research and clinical trials.

Expectations are high for a robust expansion in the market size for gastric volvulus treatment in the following years. The market is forecasted to elevate to $37.48 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. The accelerative growth predicted within this period can be accredited to adjustments in regulation, endorsements, surgical procedure innovations, a growing elderly population, personalized treatment schemes, and the adoption of advanced imaging methods. The forecast period will also see major trends like the adoption of minimally invasive surgical procedures, early intervention, and heightened awareness, advancements in treatment research, cooperative medical practices, and personal treatment strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gastric Volvulus Treatment Market?

The anticipated increase in the population of elderly adults, those aged 65 and above, is predicted to stimulate significant expansions in the gastric volvulus treatment market in the future. This age demographic is susceptible to various illnesses due to age-related declines in immunity. Gastric volvulus is one such condition predominantly affecting individuals over 50 years old. Therefore, an expansion in the geriatric population is a key factor expected to fuel the market. Moreover, data from the Population Reference Bureau (PRB), a not-for-profit body based in the U.S., disclosed in January 2024 that the segment of Americans who are 65 years and older will surge from 58 million in 2022 to 82 million in 2050, a boost of 47%. Additionally, their share of the total population will also rise from 17% to 23%. Thus, escalations in the geriatric populations stand as a strong propellant for the growth of the gastric volvulus treatment market.

Which Key Market Segments Comprise the Gastric Volvulus Treatment Market and Drive Its Revenue Growth?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Which Areas Are Leading Regions in the Gastric Volvulus Treatment Market Expansion Across the Globe?

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in the Gastric Volvulus Treatment Market Over the Coming Years?

In the gastric volvulus treatment market, product innovation is emerging as a crucial trend. To maintain their significance in the market, leading corporations are launching state-of-the-art products. Pfizer Inc., an American pharmaceutical firm, exemplified this in October 2023 when it revealed that the U.S. Food and Drug Administration (FDA) had sanctioned VELSIPITY (etrasimod). This medication, which is an oral sphingosine-1-phosphate (S1P) receptor activator, is administrated once daily for patients with moderate to severe active ulcerative colitis (UC). The recommended dosage of VELSIPITY is 2 mg. This drug enables adults with UCS to accomplish steroid-free resolution utilizing a daily oral pill that strikes a balance between benefits and risks. The FDA’s approval of VELSIPITY indicates a significant milestone for UC patients needing new treatment alternatives for their chronic condition and are prepared to commence advanced therapy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

How Is the Gastric Volvulus Treatment Market Conceptually Defined?

Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is usually simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model